Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
EGL Genetic Diagnostics, |
RCV000379757 | SCV000337974 | uncertain significance | not provided | 2015-12-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000560616 | SCV000640792 | uncertain significance | Nemaline myopathy 2 | 2019-08-05 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 135 of the NEB protein (p.Val135Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs373729655, ExAC 0.01%). This variant has not been reported in the literature in individuals with NEB-related disease. ClinVar contains an entry for this variant (Variation ID: 285101). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |